TCI Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
TCI Wealth Advisors's EBS Position: Q2 2023 in Review
TCI Wealth Advisors sold out of Emergent Biosolutions (EBS) in Q2 2023, closing a stake of 138 shares — an estimated $1.43K sold.
TCI Wealth Advisors first reported a position in EBS in Q1 2016 and held it in 26 quarters. The position peaked at $8K in Q1 2021. 182 funds tracked by Wall St. Rank hold EBS as of Q2 2023.
- TCI Wealth Advisors reported no remaining Emergent Biosolutions position as of Q2 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 138 Emergent Biosolutions shares in Q2 2023, an estimated $1.43K.
- TCI Wealth Advisors first reported a position in Emergent Biosolutions in Q1 2016 and held it in 26 quarters.
- TCI Wealth Advisors's Emergent Biosolutions position peaked at $8K in Q1 2021.
- 182 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2023.
Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.